Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment

Glioblastomas (GBM) are deadly brain tumors that currently do not have long-term patient treatments available. GBM overexpress the angiogenesis factor VEGF and its receptor VEGFR2. ETLD1 (epidermal growth factor, latrophilin and seven transmembrane domain-containing protein 1), a G-protein coupled r...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Nucl Med Mol Imaging
Main Authors: Ziegler, Jadith, Zalles, Michelle, Smith, Nataliya, Saunders, Debra, Lerner, Megan, Fung, Kar-Ming, Patel, Maulin, Wren, Jonathan D, Lupu, Florea, Battiste, James, Towner, Rheal A
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6420708/
https://ncbi.nlm.nih.gov/pubmed/30911439
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares